1 active not recruiting, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Active not recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Exercise Test: new trials by email Literature Review of Exercise Test trials Research Report on Exercise Test
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology Hyperpolarized xenon 129, Cardiopulmonary Stress Test, Pulmonary Function Test - Electronic Cigarette Related Lung Damage | Phase 2 / Phase 3 | Recruiting | Y. Michael Shim, MD | 80 | 2024-12-19 | 2026-03-17 |
| Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients Fentanyl Citrate Buccal Tablet, Morphine, Physical Performance Testing - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 3 | Active not recruiting | M.D. Anderson Cancer Center | 150 | 2020-10-23 | 2026-08-11 |
| Robotic Locomotor Experience Applied to Parkinson's Disease Lokomat®, Treadmill - Parkinson's Disease | Phase 2 / Phase 3 | Unknown | Azienda Ospedaliero Universitaria Maggiore della Carita | 28 | 2010-10-01 | 2011-09-27 |
Hematologic Neoplasms (1) · Parkinson Disease (1) · Vaping (1)
Azienda Ospedaliero Universitaria Maggiore della Carita (1) · M.D. Anderson Cancer Center (1) · Y. Michael Shim, MD (1)
United States (2) · Italy (1)
Carlo Cisari, MD (1) · David Hui (1) · Stefano Carda, MD, PhD (1) · Yun M Shim, MD (1)
R01CA231471 (1)